177 related articles for article (PubMed ID: 19661844)
41. Short-term pretreatment DCE-MRI in prediction of outcome in locally advanced cervical cancer.
Lund KV; Simonsen TG; Hompland T; Kristensen GB; Rofstad EK
Radiother Oncol; 2015 Jun; 115(3):379-85. PubMed ID: 25998804
[TBL] [Abstract][Full Text] [Related]
42. Pretreatment late-phase DCE-MRI predicts outcome in locally advanced cervix cancer.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Acta Oncol; 2017 May; 56(5):675-681. PubMed ID: 28447564
[TBL] [Abstract][Full Text] [Related]
43. Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy.
Wang JZ; Mayr NA; Zhang D; Li K; Grecula JC; Montebello JF; Lo SS; Yuh WT
Cancer; 2010 Nov; 116(21):5093-101. PubMed ID: 20629080
[TBL] [Abstract][Full Text] [Related]
44. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
[TBL] [Abstract][Full Text] [Related]
45. Temporal analysis of tumor heterogeneity and volume for cervical cancer treatment outcome prediction: preliminary evaluation.
Prescott JW; Zhang D; Wang JZ; Mayr NA; Yuh WT; Saltz J; Gurcan M
J Digit Imaging; 2010 Jun; 23(3):342-57. PubMed ID: 19172357
[TBL] [Abstract][Full Text] [Related]
46. Whole solid tumor volume histogram parameters for predicting the recurrence in patients with epithelial ovarian carcinoma: a feasibility study on quantitative DCE-MRI.
Li HM; Tang W; Feng F; Zhao SH; Gu WY; Zhang GF; Qiang JW
Acta Radiol; 2020 Sep; 61(9):1266-1276. PubMed ID: 31955611
[TBL] [Abstract][Full Text] [Related]
47. Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
Ueno Y; Lisbona R; Tamada T; Alaref A; Sugimura K; Reinhold C
Br J Radiol; 2017 Jul; 90(1075):20170035. PubMed ID: 28508679
[TBL] [Abstract][Full Text] [Related]
48. Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.
Kuchcinski G; Le Rhun E; Cortot AB; Drumez E; Duhal R; Lalisse M; Dumont J; Lopes R; Pruvo JP; Leclerc X; Delmaire C
Eur Radiol; 2017 Sep; 27(9):3733-3743. PubMed ID: 28210799
[TBL] [Abstract][Full Text] [Related]
49. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
[TBL] [Abstract][Full Text] [Related]
50. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
[TBL] [Abstract][Full Text] [Related]
51. Perfusion parameters of intravoxel incoherent motion based on tumor edge region of interest in cervical cancer: evaluation of differentiation and correlation with dynamic contrast-enhanced MRI.
Wang H; Zhu L; Li G; Zuo M; Ma X; Wang J
Acta Radiol; 2020 Aug; 61(8):1087-1095. PubMed ID: 31825761
[TBL] [Abstract][Full Text] [Related]
52. Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix.
Mayr NA; Magnotta VA; Ehrhardt JC; Wheeler JA; Sorosky JI; Wen BC; Davis CS; Pelsang RE; Anderson B; Doornbos JF; Hussey DH; Yuh WT
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):915-24. PubMed ID: 8751400
[TBL] [Abstract][Full Text] [Related]
53. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
[TBL] [Abstract][Full Text] [Related]
54. Clinical and Quantitative MRI Perfusion Analysis of Osteoid Osteomas Before and After Microwave Ablation.
Kostrzewa M; Henzler T; Schoenberg SO; Diehl SJ; Rathmann N
Anticancer Res; 2019 Jun; 39(6):3053-3057. PubMed ID: 31177148
[TBL] [Abstract][Full Text] [Related]
55. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Advanced Cervical Carcinoma: The Advantage of Perfusion Parameters From the Peripheral Region in Predicting the Early Response to Radiotherapy.
Zhang Z; Wang Z; Zhao R
Int J Gynecol Cancer; 2018 Sep; 28(7):1342-1349. PubMed ID: 29994909
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators.
Pickles MD; Lowry M; Manton DJ; Turnbull LW
Eur Radiol; 2015 Apr; 25(4):1097-106. PubMed ID: 25424563
[TBL] [Abstract][Full Text] [Related]
57. Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.
Kim YI; Yoon HJ; Paeng JC; Cheon GJ; Lee DS; Chung JK; Kim EE; Moon WK; Kang KW
Clin Nucl Med; 2016 Aug; 41(8):614-20. PubMed ID: 27276207
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of post-radiation serum squamous cell carcinoma antigen and primary tumor regression for cervical squamous cell carcinoma.
Wan Q; Yan W; Liu Y; Lin Y; Lu Z
Cancer Biomark; 2020; 29(3):327-335. PubMed ID: 32716344
[TBL] [Abstract][Full Text] [Related]
59. The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery.
Valentini AL; Miccò M; Gui B; Giuliani M; Rodolfino E; Telesca AM; Pasciuto T; Testa A; Gambacorta MA; Zannoni G; Rufini V; Giordano A; Valentini V; Scambia G; Manfredi R
Eur Radiol; 2018 Jun; 28(6):2425-2435. PubMed ID: 29318432
[TBL] [Abstract][Full Text] [Related]
60. Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer.
Testa AC; Ludovisi M; Manfredi R; Zannoni G; Gui B; Basso D; Di Legge A; Licameli A; Di Bidino R; Scambia G; Ferrandina G
Ultrasound Obstet Gynecol; 2009 Sep; 34(3):335-44. PubMed ID: 19705403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]